Hepatocellular Cancer Immunotherapy
Investigators at Tianjin Medical University publish new data on hepatocellular cancer immunotherapy
Published in Gastroenterology Week, January 12th, 2009
Fresh data on hepatocellular cancer are presented in the report 'A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.' According to a study from Tianjin, People's Republic of China, "With a resistance to conventional chemotherapy and radiotherapy, hepatocellular carcinoma has a high recurrence rate after radical resection. Adjuvant immunotherapy is a promising treatment for hepatocellular carcinoma."
"To evaluate the effect of adjuvant immunotherapy with cytokine-induced killer cells on the prognosis of hepatocellular carcinoma after radical resection. From January 2000...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- American Journal of Pathology
Safe new therapy for genetic heart disease - World Journal of Gastroenterology
A new screening test for chronic abdominal pain - World Journal of Gastroenterology
Acute gastric injury due to high-dose analgesics? - World Journal of Gastroenterology
How to enhance non-thermal effects of ultrasound - World Journal of Gastroenterology
What are protective effects of anti-ricin A-chain aptamer? - Acid Reflux Disease
Report summarizes acid reflux disease study findings from Ohio State University - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
